Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.

MLA

Donato, H., et al. “Effect of Early versus Late Administration of Human Recombinant Erythropoietin on Transfusion Requirements in Premature Infants: Results of a Randomized, Placebo-Controlled, Multicenter Trial.” Pediatrics, vol. 105, no. 5, May 2000, pp. 1066–72. EBSCOhost, https://doi.org/10.1542/peds.105.5.1066.

APA

Donato, H., Vain, N., Rendo, P., Vivas, N., Prudent, L., Larguía, M., Digregorio, J., Vecchiarelli, C., Valverde, R., García, C., Subotovsky, P., Solana, C., & Gorenstein, A. (2000). Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics, 105(5), 1066–1072. https://doi.org/10.1542/peds.105.5.1066

Chicago

Donato, H, N Vain, P Rendo, N Vivas, L Prudent, M Larguía, J Digregorio, et al. 2000. “Effect of Early versus Late Administration of Human Recombinant Erythropoietin on Transfusion Requirements in Premature Infants: Results of a Randomized, Placebo-Controlled, Multicenter Trial.” Pediatrics 105 (5): 1066–72. doi:10.1542/peds.105.5.1066.